Confronting Complexity: Real-World Immunodominance in Antiviral CD8+ T Cell Responses

Immunity

Volumn 25, Issue 4, 2006, Pages 533-543

  Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HLA A ANTIGEN; HLA B ANTIGEN; STRUCTURAL PROTEIN; T LYMPHOCYTE RECEPTOR; VIRUS DNA; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOMEGALOVIRUS; DNA REPLICATION; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HERPES VIRUS; HERPES VIRUS INFECTION; HUMAN; IMMUNOGENETICS; IMMUNOGENICITY; IMMUNOSURVEILLANCE; MODEL; MOLECULAR RECOGNITION; MOUSE STRAIN; NONHUMAN; POXVIRUS; POXVIRUS INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VACCINIA VIRUS; VIRUS GENOME; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNODOMINANT EPITOPES; MICE; VIRUS DISEASES; VIRUSES;

EID: 33749528390     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.09.005     Document Type: Review

References (101)

1. Ali A., Lubong R., Ng H., Brooks D.G., Zack J.A., and Yang O.O. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J. Virol. 78 (2004) 561-567
2. + elite suppressors despite CTL escape mutations. J. Exp. Med. 203 (2006) 1357-1369
3. +) T cells. J. Immunol. 168 (2002) 5403-5408
4. + T cell response to influenza A viruses. J. Immunol. 165 (2000) 2404-2409
5. +) T cell responses. J. Immunol. 166 (2001) 4627-4633
6. +) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype. J. Virol. 74 (2000) 9144-9151
7. Bihl F., Frahm N., Di Giammarino L., Sidney J., John M., Yusim K., Woodberry T., Sango K., Hewitt H.S., Henry L., et al. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 176 (2006) 4094-4101
8. Boon A.C., De Mutsert G., Fouchier R.A., Sintnicolaas K., Osterhaus A.D., and Rimmelzwaan G.F. Preferential HLA usage in the influenza virus-specific CTL response. J. Immunol. 172 (2004) 4435-4443
9. Borghans J.A., and De Boer R.J. Crossreactivity of the T-cell receptor. Immunol. Today 19 (1998) 428-429
10. Brehm M.A., Pinto A.K., Daniels K.A., Schneck J.P., Welsh R.M., and Selin L.K. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 3 (2002) 627-634
11. Bronte V., Carroll M.W., Goletz T.J., Wang M., Overwijk W.W., Marincola F., Rosenberg S.A., Moss B., and Restifo N.P. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc. Natl. Acad. Sci. USA 94 (1997) 3183-3188
12. Bunde T., Kirchner A., Hoffmeister B., Habedank D., Hetzer R., Cherepnev G., Proesch S., Reinke P., Volk H.D., Lehmkuhl H., et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201 (2005) 1031-1036
13. Burrows S.R., Silins S.L., Moss D.J., Khanna R., Misko I.S., and Argaet V.P. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J. Exp. Med. 182 (1995) 1703-1715
14. Chen W., Anton L.C., Bennink J.R., and Yewdell J.W. Dissecting the multifactorial causes of immunodominance in class I- restricted T cell responses to viruses. Immunity 12 (2000) 83-93
15. +) T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193 (2001) 1319-1326
16. + T-cell responses to influenza virus. J. Virol. 76 (2002) 10332-10337
17. + T cell responses to influenza A virus: Roles for cross-presentation and lysis-independent immunodomination. J. Immunol. 173 (2004) 5021-5027
18. Choi E.Y., Christianson G.J., Yoshimura Y., Sproule T.J., Jung N., Joyce S., and Roopenian D.C. Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide. Immunity 17 (2002) 593-603
19. Crotzer V.L., Christian R.E., Brooks J.M., Shabanowitz J., Settlage R.E., Marto J.A., White F.M., Rickinson A.B., Hunt D.F., and Engelhard V.H. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines. J. Immunol. 164 (2000) 6120-6129
20. Crowe S.R., and Woodland D.L. T-cell specificity and respiratory infections. In: Frelinger J.A. (Ed). Immunodominance: The Choice of the Immune System (2006), Wiley-VCH, Weinheim 189-208
21. + T cell immunodominance in primary and secondary influenza virus infections. J. Exp. Med. 198 (2003) 399-410
22. Crowe S.R., Miller S.C., Shenyo R.M., and Woodland D.L. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge. J. Immunol. 174 (2005) 696-701
23. Crowe S.R., Miller S.C., and Woodland D.L. Identification of protective and non-protective T cell epitopes in influenza. Vaccine 24 (2006) 452-456
24. Davis M.M. The problem of plain vanilla peptides. Nat. Immunol. 4 (2003) 649-650
25. Draenert R., Allen T.M., Liu Y., Wrin T., Chappey C., Verrill C.L., Sirera G., Eldridge R.L., Lahaie M.P., Ruiz L., et al. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus. J. Exp. Med. 203 (2006) 529-539
26. Ely L.K., Beddoe T., Clements C.S., Matthews J.M., Purcell A.W., Kjer-Nielsen L., McCluskey J., and Rossjohn J. Disparate thermodynamics governing T cell receptor-MHC-I interactions implicate extrinsic factors in guiding MHC restriction. Proc. Natl. Acad. Sci. USA 103 (2006) 6641-6646
27. Frahm N., Adams S., Kiepiela P., Linde C.H., Hewitt H.S., Lichterfeld M., Sango K., Brown N.V., Pae E., Wurcel A.G., et al. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J. Virol. 79 (2005) 10218-10225
28. Fu T.M., Mylin L.M., Schell T.D., Bacik I., Russ G., Yewdell J.W., Bennink J.R., and Tevethia S.S. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. J. Virol. 72 (1998) 1469-1481
29. Gaddis D.E., Fuller M.J., and Zajac A.J. CD8 T-cell immunodominance, repertoire, and memory. In: Frelinger J.A. (Ed). Immunodominance: The Choice of the Immune System (2006), Wiley-VCH, Weinheim
30. Gold M.C., Munks M.W., Wagner M., Koszinowski U.H., Hill A.B., and Fling S.P. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. J. Immunol. 169 (2002) 359-365
31. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Schreiber R., and Chisari F.V. Intracellular inactivation of the Hepatitis B virus by cytotoxic T lymphocytes. Immunity 4 (1996) 25-36
32. + T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes. J. Virol. 80 (2006) 5509-5515
33. Istrail S., Florea L., Halldorsson B.V., Kohlbacher O., Schwartz R.S., Yap V.B., Yewdell J.W., and Hoffman S.L. Comparative immunopeptidomics of humans and their pathogens. Proc. Natl. Acad. Sci. USA 101 (2004) 13268-13272
34. Ito Y., Kondo E., Demachi-Okamura A., Akatsuka Y., Tsujimura K., Tanimoto M., Morishima Y., Takahashi T., and Kuzushima K. Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation. J. Virol. 80 (2006) 883-890
35. Jamieson B.D., and Ahmed R. T cell memory. Long-term persistence of virus-specific cytotoxic T cells. J. Exp. Med. 169 (1989) 1993-2005
36. Jing L., Chong T.M., McClurkan C.L., Huang J., Story B.T., and Koelle D.M. Diversity in the acute CD8 T cell response to vaccinia virus in humans. J. Immunol. 175 (2005) 7550-7559
37. + T-cell responses driven by recombinant cytomegaloviruses. J. Virol. 78 (2004) 2255-2264
38. Kedl R.M., Kappler J.W., and Marrack P. Epitope dominance, competition and T cell affinity maturation. Curr. Opin. Immunol. 15 (2003) 120-127
39. Kim S.K., Cornberg M., Wang X.Z., Chen H.D., Selin L.K., and Welsh R.M. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J. Exp. Med. 201 (2005) 523-533
40. Kjer-Nielsen L., Clements C.S., Purcell A.W., Brooks A.G., Whisstock J.C., Burrows S.R., McCluskey J., and Rossjohn J. A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 18 (2003) 53-64
41. Kjer-Nielsen L., Dunstone M.A., Kostenko L., Ely L.K., Beddoe T., Misfud N.A., Purcell A.W., Brooks A.G., McCluskey J., and Rossjohn J. Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3. Proc. Natl. Acad. Sci. USA 101 (2004) 7675-7680
42. + T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc. Natl. Acad. Sci. USA 103 (2006) 994-999
43. Landais E., Saulquin X., and Houssaint E. The human T cell immune response to Epstein-Barr virus. Int. J. Dev. Biol. 49 (2005) 285-292
44. Lehner P.J., Wang E.C., Moss P.A., Williams S., Platt K., Friedman S.M., Bell J.I., and Borysiewicz L.K. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J. Exp. Med. 181 (1995) 79-91
45. +) T-cell responses in acute HIV-1 infection: At the crossroads of viral and host genetics. Trends Immunol. 26 (2005) 166-171
46. + T cells initiate IFN-gamma synthesis increases markedly over the course of infection and correlates with immunodominance. J. Immunol. 173 (2004) 456-462
47. Lu X., Pinto A.K., Kelly A.M., Cho K.S., and Hill A.B. Murine cytomegalovirus interference with antigen presentation contributes to the inability of CD8 T cells to control virus in the salivary gland. J. Virol. 80 (2006) 4200-4202
48. Maini M., and Bertoletti A. The effects of pathogens on the immune sytstem: Viral hepatitis. In: Frelinger J.A. (Ed). Immunodominance: The Choice of the Immune System (2006), Wiley-VCH, Weinheim
49. + cytotoxic T-cell response in natural infection. Blood 104 (2004) 1075-1082
50. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19 (1998) 395-404
51. Meijers R., Lai C.C., Yang Y., Liu J.H., Zhong W., Wang J.H., and Reinherz E.L. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: Implications for TCR repertoire selection and immunodominance. J. Mol. Biol. 345 (2005) 1099-1110
52. Messaoudi I., Guevara Patino J.A., Dyall R., LeMaoult J., and Nikolich-Zugich J. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 298 (2002) 1797-1800
53. *5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. USA 97 (2000) 2709-2714
54. Moss P.A., Moots R.J., Rosenberg W.M., Rowland-Jones S.J., Bodmer H.C., McMichael A.J., and Bell J.I. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. USA 88 (1991) 8987-8990
55. +)-cell responses to vaccinia virus. Nat. Biotechnol. 24 (2006) 817-819 10.1038/nbt1215 Published online June 11, 2006
56. Munks M.W., and Hill A.B. Immunodominance in the T-cell response to herpesviruses. In: Frelinger J.A. (Ed). Immunodominance: The Choice of the Immune System (2006), Wiley-VCH, Weinheim 255-284
57. Munks M.W., Gold M.C., Zajac A.L., Doom C.M., Morello C.S., Spector D.H., and Hill A.B. Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J. Immunol. 176 (2006) 3760-3766
58. Murgia C., Pritchard J.K., Kim S.Y., Fassati A., and Weiss R.A. Clonal Origin and Evolution of a Transmissible Cancer. Cell 126 (2006) 477-487
59. + T cells by infected dendritic cells in vivo. Nat. Immunol. 3 (2002) 265-271
60. Oseroff C., Kos F., Bui H.H., Peters B., Pasquetto V., Glenn J., Palmore T., Sidney J., Tscharke D.C., Bennink J.R., et al. HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc. Natl. Acad. Sci. USA 102 (2005) 13980-13985
61. *0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J. Immunol. 175 (2005) 5504-5515
62. Pearse A.M., and Swift K. Allograft theory: Transmission of devil facial-tumour disease. Nature 439 (2006) 549
63. Pozzi L.A., Maciaszek J.W., and Rock K.L. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J. Immunol. 175 (2005) 2071-2081
64. Restifo N.P., Bacik I., Irvine K.R., Yewdell J.W., McCabe B., Anderson R.W., Eisenlohr L.C., Rosenberg S.A., and Bennink J.R. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154 (1995) 4414-4422
65. +) T-cell populations with differing cytolytic activities. J. Virol. 75 (2001) 7399-7409
66. +) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon. J. Virol. 76 (2002) 4251-4259
67. Rosenthal K.L., and Zinkernagel R.M. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk. J. Immunol. 126 (1981) 446-451
68. Sacre K., Carcelain G., Cassoux N., Fillet A.M., Costagliola D., Vittecoq D., Salmon D., Amoura Z., Katlama C., and Autran B. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J. Exp. Med. 201 (2005) 1999-2010
69. Saveanu L., Carroll O., Hassainya Y., and van Endert P. Complexity, contradictions, and conundrums: Studying post-proteasomal proteolysis in HLA class I antigen presentation. Immunol. Rev. 207 (2005) 42-59
70. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., and Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11 (1993) 729-766
71. Sette A., and Fikes J. Epitope-based vaccines: An update on epitope identification, vaccine design and delivery. Curr. Opin. Immunol. 15 (2003) 461-470
72. Sette A., and Sundaram R. The phenomenon of immunodomination: Speculations on the nature of immunodominance. In: Frelinger J.A. (Ed). Immunodominance: The Choice of the Immune System (2006), Wiley-VCH, Weinheim 57-72
73. + CTL following exposure to vaccinia virus via different routes. J. Immunol. 169 (2002) 4222-4229
74. Slev P.R., Nelson A.C., and Potts W.K. Sensory neurons with MHC-like peptide binding properties: Disease consequences. Curr. Opin. Immunol. 18 (2006) 608-616 10.1016/j.coi.2006.07.012 Published online August 1, 2006
75. Snyder-Cappione J.E., Divekar A.A., Maupin G.M., Jin X., Demeter L.M., and Mosmann T.R. HIV-specific cytotoxic cell frequencies measured directly ex vivo by the Lysispot assay can be higher or lower than the frequencies of IFN-{gamma}-secreting cells: Anti-HIV cytotoxicity is not generally impaired relative to other chronic virus responses. J. Immunol. 176 (2006) 2662-2668
76. Stewart-Jones G.B., McMichael A.J., Bell J.I., Stuart D.I., and Jones E.Y. A structural basis for immunodominant human T cell receptor recognition. Nat. Immunol. 4 (2003) 657-663
77. Strehl B., Seifert U., Kruger E., Heink S., Kuckelkorn U., and Kloetzel P.M. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol. Rev. 207 (2005) 19-30
78. + T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202 (2005) 673-685
79. Trautmann L., Rimbert M., Echasserieau K., Saulquin X., Neveu B., Dechanet J., Cerundolo V., and Bonneville M. Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses. J. Immunol. 175 (2005) 6123-6132
80. + T cell vaccine design. Expert Opin. Biol. Ther. 5 (2005) 263-271
81. + T cell determinants to enable rational design and characterization of smallpox vaccines 3. J. Exp. Med. 201 (2005) 95-104
82. + T-cell determinants and cross-reactivity in BALB/c mice. J. Virol. 80 (2006) 6318-6323
83. + T cell populations. Nat. Immunol. 6 (2005) 382-389
84. Urbani S., Amadei B., Fisicaro P., Pilli M., Missale G., Bertoletti A., and Ferrari C. Heterologous T cell immunity in severe hepatitis C virus infection. J. Exp. Med. 201 (2005) 675-680
85. van der Most R.G., Murali-Krishna K., Lanier J.G., Wherry E.J., Puglielli M.T., Blattman J.N., Sette A., and Ahmed R. Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology 315 (2003) 93-102
86. Wallace M.E., Keating R., Heath W.R., and Carbone F.R. The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J. Virol. 73 (1999) 7619-7626
87. Wedemeyer H., Mizukoshi E., Davis A.R., Bennink J.R., and Rehermann B. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J. Virol. 75 (2001) 11392-11400
88. Welsh R.M. Private specificities of heterologous immunity. Curr. Opin. Immunol. 18 (2006) 331-337
89. Welsh R.M., and Selin L.K. No one is naive: The significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2 (2002) 417-426
90. Welsh R.M., Selin L.K., and Szomolanyi-Tsuda E. Immunological memory to viral infections. Annu. Rev. Immunol. 22 (2004) 711-743
91. Wherry E.J., Puorro K.A., Porgador A., and Eisenlohr L.C. The induction of virus-specific CTL as a function of increasing epitope expression: Responses rise steadily until excessively high levels of epitope are attained. J. Immunol. 163 (1999) 3735-3745
92. Whitton J.L., Slifka M.K., Liu F., Nussbaum A.K., and Whitmire J.K. The regulation and maturation of antiviral immune responses. Adv. Virus Res. 63 (2004) 181-238
93. Woodberry T., Suscovich T.J., Henry L.M., Davis J.K., Frahm N., Walker B.D., Scadden D.T., Wang F., and Brander C. Differential targeting and shifts in the immunodominance of Epstein-Barr virus-specific CD8 and CD4 T cell responses during acute and persistent infection. J. Infect. Dis. 192 (2005) 1513-1524
94. Yang O.O., Church J., Kitchen C.M., Kilpatrick R., Ali A., Geng Y., Killian M.S., Sabado R.L., Ng H., Suen J., et al. Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins. J. Virol. 79 (2005) 15368-15375
95. Yang O.O., Sarkis P.T., Trocha A., Kalams S.A., Johnson R.P., and Walker B.D. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL. J. Immunol. 171 (2003) 3718-3724
96. Yewdell J.W. The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunol. Rev. 207 (2005) 1-11
97. Yewdell J.W., and Bennink J.R. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17 (1999) 51-88
98. Yewdell J.W., and Del Val M. Immunodominance in CD8+ T cell responses to viruses: Cell biology, cellular immunology, and mathematical models. Immunity 21 (2004) 149-153
99. + T cells in vivo: The key to rational vaccine design. Annu. Rev. Immunol. 23 (2005) 651-682
100. York I.A., Brehm M.A., Zendzian S., Towne C.F., and Rock K.L. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc. Natl. Acad. Sci. USA 103 (2006) 9202-9207
101. + T-cell responses following acute HIV-1 infection. J. Virol. 76 (2002) 8690-8701